900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Adverse reaction to dietetics	Ambiguous
Adverse reaction to digestants NOS	Limited component (foundation metadata concept)
Adverse reaction to digitoxin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to digoxin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to digoxin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to dihydrocodeine tartrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to diloxanide furoate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to dioctyl sodium sulfosuccinate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to diphenylpyraline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to diphtheria vaccine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to dipipanone hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to dipyridamole	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to distigmine bromide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to diuretic NOS	Limited component (foundation metadata concept)
Adverse reaction to dothiepin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to doxapram	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to doxepin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to doxorubicin hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to doxycycline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to drug NOS	Classification derived component
Adverse reaction to drug NOS	Classification derived component
Adverse reaction to drug or medicinal substance NOS	Limited component (foundation metadata concept)
Adverse reaction to drug primarily affecting the autonomic nervous system NOS	Classification derived component
Adverse reaction to drug primarily affecting the cardiovascular system NOS	Classification derived component
Adverse reaction to drug primarily affecting the cardiovascular system NOS	Classification derived component
Adverse reaction to drugs primarily affecting autonomic nervous system	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting gastrointestinal system	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting gastrointestinal system	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting skin and mucous membrane, ophthalmological, otorhinolaryngological and dental drugs	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting the cardiovascular system	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting the cardiovascular system	A component that fails to comply with the current editorial guidance.
Adverse reaction to drugs primarily affecting the gastrointestinal system NOS	Classification derived component
Adverse reaction to drugs: [antirheumatics] or [NSAID]	Ambiguous
Adverse reaction to dydrogesterone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to edrophonium chloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to electrolytic, caloric and water balance drugs	Ambiguous
Adverse reaction to emetics NOS	Limited component (foundation metadata concept)
Adverse reaction to emollient cathartic NOS	Limited component (foundation metadata concept)
Adverse reaction to enalapril	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to enflurane	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to enzymes NEC	Limited component (foundation metadata concept)
Adverse reaction to enzymes NOS	Limited component (foundation metadata concept)
Adverse reaction to ephedrine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ergometrine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to erythromycin	Ambiguous
Adverse reaction to erythromycin and other macrolides	Limited component (foundation metadata concept)
Adverse reaction to estradiol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to estramustine phosphate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to estriol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethacrynic acid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethambutol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethamivan	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethamsylate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethanolamine oleate	Ambiguous
Adverse reaction to ether	Ambiguous
Adverse reaction to ethinylestradiol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ethosuximide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to etomidate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to etoposide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to expectorants NOS	Limited component (foundation metadata concept)
Adverse reaction to eye anti-infectives and other eye drugs	Ambiguous
Adverse reaction to eye drugs NOS	Ambiguous
Adverse reaction to fenoprofen	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ferric salts	Ambiguous
Adverse reaction to ferrous fumarate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ferrous gluconate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ferrous glycine sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ferrous succinate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ferrous sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fibrinolytic drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to flucloxacillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flucytosine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fludrocortisone acetate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fluorouracil	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flupenthixol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fluphenazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flurazepam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flurbiprofen	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to folic acid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to framycetin sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to furosemide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gallamine triethiodide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gamma globulin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ganglion blockers NOS	Limited component (foundation metadata concept)
Adverse reaction to gaseous anesthetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gaseous anesthetic NOS	Limited component (foundation metadata concept)
Adverse reaction to general anesthetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gentamicin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glibenclamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gliclazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glipizide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gliquidone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glucagon	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glycerol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glyceryl trinitrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glymidine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to griseofulvin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to guanethidine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hallucinogen NOS	Limited component (foundation metadata concept)
Adverse reaction to haloperidol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to halothane	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 78 of 1405 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)